Officers & Councilors
Jo received her PhD from St Bartholomew’s Hospital, University of London in 1991 and pursued postdoctoral fellowships at the Imperial Cancer Research Fund in London, UK, and at Genentech in the Bay Area, California. Following her training, Jo joined Immunex in 1995 and remained at the company, which was acquired by Amgen in 2002, until leaving to join Biogen.
Jo has advanced a portfolio of novel biologic and small molecule programs, ten of which have progressed to IND and into clinical development, for diseases such rheumatoid arthritis, asthma, atopic dermatitis, psoriasis, inflammatory bowel disease, lupus and Sjogren’s syndrome.
Jo has maintained longstanding membership with the American Society of Immunologists (AAI), the British Society for Immunology (BSI) and the Society for Mucosal Immunology (SMI). She served as President of SMI from 2011-2013. Together with SMI colleagues, she launched the journal Mucosal Immunology with Nature Publishing Group in 2007. Jo received the SMI’s Distinguished Service Award in 2015.
Jo has been a member of the Scientific Advisory Board for Keystone Symposia since 2008. In addition to her SAB duties, Jo partners with Keystone on a number of programs for under-represented scientists. At Biogen, Jo is an active member and supporter of both REACHOUT (The LGBTQ & Allies Employee Resource Network) and WIN (The Employee Resource Network for Women; she is currently co-chair of the WIN Global Steering Committee). Outside of Biogen, Jo is on the Board of WEST, a Boston-based non-profit learning community with the mission to provide women in STEM with the inspiration, knowledge, and connections to reach their full potential.
Jo serves on the Board of Directors for Ataxion Inc in Cambridge, MA, and is a member of the Scientific Advisory Board for Vaxart Inc in the Bay Area.
and later by a fellowship from the Crohn’s and Colitis Foundation of America. In Eugene’s lab, she started working on the transcriptional regulation of intestinal dendritic cell subsets, as well as their role in the coordination of the immune response towards rotavirus. Dr. Lahl recently was awarded a young investigator award from the Swedish Research Council, as well as a fellowship in medicine by the Ragnar Söderberg Foundation. Intestinal dendritic cell biology and rotavirus are still what she is working
on today in her lab in Scandinavia, which is split between the Technical University of Denmark in Copenhagen and Lund University in Sweden.
important cytokine in modulating tissue responses during inflammation. Her research revealed both a protective and pathologic role for IL-22 in the inflamed gastrointestinal tract. Her studies also showed that IL-22 has effects on the host microbiota, causing changes in flora composition that can lead to exacerbated colitis. Through her research, Dr. Zenewicz identified that both T cells and innate lymphocytes are an important source of IL-22. Her laboratory is now focused on investigating the role of
environmental factors in the regulation of IL-22 expression in T cells and innate lymphocytes.